The Health Resources and Services Administration (HRSA) faces a key deadline today to approve drugmakers’ 340B rebate pilot proposals—but uncertainty [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.